Loading clinical trials...
Loading clinical trials...
REALL CD9 : Molecular Mechanisms Involved in Relapses of Childhood B-acute Lymphoblastic Leukaemia, Role of Non-coding RNA in CD9 Gene Regulation
Conditions
Interventions
Sampling bone tissue and blood
Locations
3
France
CHU Angers
Angers, France
CHU Brest
Brest, France
CHU Rennes
Rennes, France
Start Date
March 22, 2025
Primary Completion Date
April 1, 2035
Completion Date
April 1, 2035
Last Updated
January 2, 2026
Lead Sponsor
Rennes University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions